The global diabetes market is experiencing rapid growth driven by the increasing prevalence of this chronic disease. At the forefront of this evolution are leading developers of GLP-1 receptor agonists, a class of https://caraxsrz191842.blogsidea.com/43924616/leading-glp-1-manufacturers-innovation-in-diabetes-treatment